15-Bio ApS: Financial statements 2019
CVR: 39889277
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
15-Bio ApS (CVR 39889277) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -12,501 and a net result of DKK -22,107. Equity in the 2019 report amounted to DKK 43,294. The solvency ratio was 95%.
- Gross Profit
- DKK -12,501
- Profit/Loss
- DKK -22,107
- Equity
- DKK 43,294
- Total Assets
- DKK 45,562
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
As of August 13, 2019, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of 15-Bio ApS.
As of August 13, 2019, EY Godkendt Revisionspartnerselskab has stepped down as auditor of 15-Bio ApS.
15-Bio ApS has published its interim report for the period September 25, 2018 – December 31, 2018.
As of June 11, 2019, EY Godkendt Revisionspartnerselskab has been appointed auditor of 15-Bio ApS.
On June 11, 2019, the company changed its name from Rasmus Jorgensen IVS to Rasmus Jorgensen Holdings ApS.
About 15-Bio ApS
15-Bio ApS is a Danish company of the type Anpartsselskab based in Værløse, founded in 2018. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named Rasmus Jorgensen Holdings ApS and Rasmus Jorgensen IVS. The management consists of Rasmus Jørgensen. The company is owned by Rasmus Jørgensen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -6,875 and a net result of DKK -6,875 compared with DKK -8,126 the year before. Equity in the 2025 report amounted to DKK 11,547.